Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention
about
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysisLack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseasePlatelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patientsCritical Overview on the Benefits and Harms of Aspirin.Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyAspirin and clopidogrel response variability: review of the published literatureDiabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationAspirin resistance: disparities and clinical implications.Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence.Antithrombotic therapy for the CardioWest temporary total artificial heart.Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus.Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.Abundance- and Activity-Based Proteomics in Platelet Biology.A contemporary viewpoint on 'aspirin resistance'.Overcoming aspirin treatment failure in diabetes.Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.Clopidogrel resistance: fact and fiction.Platelet aggregation pathway.Vascular and platelet responses to aspirin in patients with coronary artery disease.Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study ("Control de HIperglucemia y Actividad PlaquetaCOX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.Monitoring of acetyl salicylic acid-induced platelet inhibition with impedance aggregometry in children with systemic-to-pulmonary shunts.Effects of omega-3 polyunsaturated fatty acids and aspirin, alone and combined, on canine platelet function.Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment.
P2860
Q24645413-8FF5EB4E-AEB6-42D7-B913-8B3934B2408CQ28211198-005C0750-5C64-4DE0-838D-922381D28386Q28220600-CC7BDF7B-69B7-4752-8AA7-BFC8219114CCQ33664298-7A47A422-B3C6-43B3-9ECC-060EE6C458A0Q35755253-7707A881-E7BD-4BA8-96D9-E6C2698F92A7Q36932221-1BFFC20C-7436-453B-A8E0-5B563A50991DQ37167506-51E00D1B-7DD2-457D-B38E-BCB353E18D12Q37227512-386B8F4B-F41B-4502-A78C-417F9D7B552BQ37428365-645F57A2-7C0C-4E98-8DD1-7E807BABF006Q37458916-7DF4F9E9-B6F7-4103-93E2-4E1A853FF98FQ37608580-EE65559D-D889-4A8A-9291-017BE369459CQ37733290-D567ABC3-CBCA-4995-9AE4-A3CB4BE762BCQ37752222-778BA3F5-821F-423E-9223-CE2A511CEFD0Q37782025-39E65C6F-643C-4E79-9EDF-2424B534E554Q37797795-44E516D6-F2A5-4584-8195-F6AC9C498D30Q37981642-97B176C2-9725-4613-8C68-F37CA53E6521Q37989558-171DB571-DC0C-4643-928F-77EC1333077BQ38055245-00CBAC70-1836-4681-9B33-A84FAD8347AFQ38087381-7FEC3711-5F58-4FEB-93FB-74C04F60B043Q38806725-8C9D3190-107F-4CBA-8220-37F88210AA41Q40347840-93FDB9E7-941F-4E08-B1B2-E4F19879F17FQ42796609-A674FF3B-393E-4ACC-B8E9-E8E950888DA7Q43970520-EF2A29A9-1BE9-4B86-A7FB-CDB4A11DA75DQ44708534-BB29F795-DAAB-488A-82DE-5158A26EA424Q46061276-3E06030F-1BE4-4399-8C0C-46F44A943508Q46087815-EF928C74-2272-4710-8787-95A5DFCB5804Q48155162-3D51C4D6-A663-4A24-8ABD-2E09204363C1Q50098017-149BA149-029C-4516-A9B1-1A95AE1BA774Q51505075-9A8000AC-4768-42F7-B603-9B0237703590
P2860
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Influence of aspirin resistanc ...... utaneous coronary intervention
@ast
Influence of aspirin resistanc ...... utaneous coronary intervention
@en
Influence of aspirin resistanc ...... utaneous coronary intervention
@nl
type
label
Influence of aspirin resistanc ...... utaneous coronary intervention
@ast
Influence of aspirin resistanc ...... utaneous coronary intervention
@en
Influence of aspirin resistanc ...... utaneous coronary intervention
@nl
prefLabel
Influence of aspirin resistanc ...... utaneous coronary intervention
@ast
Influence of aspirin resistanc ...... utaneous coronary intervention
@en
Influence of aspirin resistanc ...... utaneous coronary intervention
@nl
P2093
P1476
Influence of aspirin resistanc ...... utaneous coronary intervention
@en
P2093
Antonio Fernandez-Ortiz
Camino Bañuelos
Carlos Macaya
Celia Ramírez
Dominick J Angiolillo
Esther Bernardo
Fernando Alfonso
Javier Escaned
Manel Sabaté
Marco A Costa
P356
10.1016/J.AMJCARD.2005.07.106
P407
P50
P577
2005-11-07T00:00:00Z